Investor Presentaiton slide image

Investor Presentaiton

Committed to Driving Scientific Advancement Focused on ensuring patient safety and reducing animal use Advancing the 4Rs Microbial business launched EndosafeⓇ Trillium®, our new animal-free recombinant test for endotoxin detection, in July 2023 Invest in innovation to broaden our reach through strategic partnerships for cutting-edge technologies that promote in vitro methods Partnerships with BitBio (iPSC-derived human cells) and Cypre (3D tumor modeling platform; immuno-oncology assays) Partnered with PathoQuest in 2020 to access an in vitro next-generation sequencing (NGS) platform for viral safety testing Virtual control groups (VCGs) as an alternative to animals in toxicity studies, to reduce animal usage, lower costs, free capacity, and increase statistical power Charles River Laboratories (CRL) 7
View entire presentation